Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study

被引：1
|
作者：
Soh Saitoh
Yuh Sakata
机构：
[1] Aomori Prefectural Central Hospital,
[2] Misawa Municipal Hospital,undefined
来源：
Gastric Cancer | 2002年 / 5卷 / Suppl 1期
关键词：
Docetaxel; Cisplatin; Gastric cancer;
D O I：
10.1007/s10120-002-0209-0
中图分类号：
学科分类号：
摘要：
Two phase II monotherapy studies of docetaxel in patients with advanced gastric cancer were performed in Japan. In group A, docetaxel showed an overall response rate of 23.7% (14/59) in 59 patients, and the adverse reactions were tolerable. In group B, this agent showed the same response rate, of 23.7% (14/59) and the same adverse reaction profile.
引用
收藏
页码：23 / 26
页数：3
相关论文
共 50 条
  • [31] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Park, YH
    Ryoo, BY
    Choi, SJ
    Kim, HT
    BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1329 - 1333
  • [32] Phase II study of docetaxel (D) as salvage chemotherapy in patients with advanced gastric cancer
    Wilke, H
    Vanhoefer, U
    Harstrick, A
    Achterrath, W
    Preusser, P
    Clemens, MR
    Thiel, E
    Flasshove, M
    Fink, U
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 52 - 52
  • [33] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Park, Keon Woo
    Ahn, Jin Seok
    Park, Young Suk
    Lee, Jeeyun
    Kang, Jung Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Im, Young-Hyuck
    Kang, Won Ki
    Park, Keunchil
    Lee, Soon Il
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 17 - 21
  • [34] Phase I study of docetaxel, cisplatin and concurrent radiotherapy for locally advanced gastric adenocarcinoma
    Xing, L.
    Lu, H.
    Zhang, J.
    Yu, J.
    Wang, F.
    Yu, X.
    Yu, H.
    Xia, L.
    NEOPLASMA, 2012, 59 (04) : 370 - 375
  • [35] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Keon Woo Park
    Jin Seok Ahn
    Young Suk Park
    Jeeyun Lee
    Jung Hoon Kang
    Joon Oh Park
    Ho Yeong Lim
    Young-Hyuck Im
    Won Ki Kang
    Keunchil Park
    Soon Il Lee
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 17 - 21
  • [36] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Kim, Young Saing
    Sym, Sun Jin
    Park, Se Hoon
    Park, Inkeun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Woon Ki
    Chung, Min
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 163 - 169
  • [37] Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer
    Yamaguchi, Kensei
    Fuse, Nozomu
    Komatsu, Yoshito
    Fujii, Hirofumi
    Hironaka, Shuichi
    Omuro, Yasushi
    Muro, Kei
    Yasui, Hirofumi
    Ueda, Shinya
    Nishina, Tomohiro
    Watanabe, Morihiro
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (06) : 879 - 885
  • [38] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Young Saing Kim
    Sun Jin Sym
    Se Hoon Park
    Inkeun Park
    Junshik Hong
    Hee Kyung Ahn
    Jinny Park
    Eun Kyung Cho
    Woon Ki Lee
    Min Chung
    Jae Hoon Lee
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 163 - 169
  • [39] Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
    Boku, Narikazu
    Muro, Kei
    Machida, Nozomu
    Hashigaki, Satoshi
    Kimura, Nobuyuki
    Suzuki, Mie
    Lechuga, Mariajose
    Miyata, Yoshinori
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 261 - 270
  • [40] Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
    Narikazu Boku
    Kei Muro
    Nozomu Machida
    Satoshi Hashigaki
    Nobuyuki Kimura
    Mie Suzuki
    Mariajose Lechuga
    Yoshinori Miyata
    Investigational New Drugs, 2014, 32 : 261 - 270
12345